Proceedings of the Shevchenko Scientific Society. Medical Sciences最新文献

{"title":"DIAGNOSTIC PREDICTORS OF TOLERANCE DEVELOPMENT IN THE ELIMINATION DIET IN CHILDREN WITH COW'S MILK PROTEIN ALLERGY","authors":"O. Matsyura, L. Besh, N. Lukyanenko, Oksana Kovalska, Kh.B. Slivinska-Kurchak, Yaryna Nagurna","doi":"10.25040/ntsh2021.01.14","DOIUrl":"https://doi.org/10.25040/ntsh2021.01.14","url":null,"abstract":"Background. Cow's milk protein allergy is a topical issue in pediatrics. This disease affects 2-3% of young children. Methods. The study included 30 children with a confirmed cow’s milk protein allergy and a prescribed milk elimination diet. The children were observed for 36 months. The molecular profile was evaluated by detecting the major components of milk (Bos d 8, Bos d 5, Bos d 4), minor (Bos d 6), and cross-reactive with serum albumin (Fel d 2, Can f 3). Results. The study group included 46.7% of boys. The mean age of the subjects was 14.5±3.18 months. Nine of the 25 analyzed factors were identified in the course of our work by the method of logistic regression with progressive selection, which in combined action affect the formation of tolerance to cow's milk proteins in allergic children. There are three clinical examples of calculating the prediction of the complete tolerance development in the elimination diet in children with cow's milk protein allergy. Conclusions. Independent predictors that reduce the likelihood of the tolerance development in the elimination diet, have identified: skin test to milk, Bos d 8, Bos d 5, Bos d 4, Bos d 6. Independent predictors of the tolerance development in the elimination diet are: milk-specific IgE, total IgE, Fel d 2, Can f 3. Low probability of tolerance development by elimination therapy is a recommendation for prescribing treatment to a patient by specific oral tolerance induction.","PeriodicalId":140699,"journal":{"name":"Proceedings of the Shevchenko Scientific Society. Medical Sciences","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121439808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A protocol for the detection of genetic markers in saliva by polymerase chain reaction without a nucleic acid purification step: examples of SARS-CoV-2 and GAPDH markers.","authors":"S. Kannan, J. Ericsson, N. Souchelnytskyi, S. Souchelnytskyi","doi":"10.25040/NTSH2021.01.16","DOIUrl":"https://doi.org/10.25040/NTSH2021.01.16","url":null,"abstract":"Background: The objective of this study was to develop a protocol for direct use of saliva in tests for genetic markers, without purification of nucleic acids. Currently, diagnostic tests use purified nucleic acids from clinical samples. This purification step adds time, cost, and affects the quality of testing. Multiple attempts to remove the purification step were reported. Results: We report a protocol for the direct detection of genetic markers in saliva. The protocol is based on collection of saliva in a solution containing a detergent and ethanol, and is compatible with isothermal amplification (LAMP), real-time RT-PCR and RT-PCR. SARS-CoV-2 and GAPDH markers were used as reference markers. We observed that mild detergents allow efficient detection of markers (e.g. GAPDH and SARS-CoV-2), while strong detergent, e.g. sodium dodecyl sulfate, inhibited the PCR reaction. Under these conditions, saliva samples can be stored for 24 h at +40C or -180C with preservation of the markers. Storage at room temperature led to deterioration of marker detection. Snap heating of saliva samples at the time of collection, followed by a storage at the room temperature, provided partial protection.Conclusions: The protocol presented in this report describes collection and storage of saliva for direct detection of genetic markers and is compatible with PCR and LAMP tests.","PeriodicalId":140699,"journal":{"name":"Proceedings of the Shevchenko Scientific Society. Medical Sciences","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124762411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"MODULATION OF MELOXICAM-INDUCED CHANGES IN GASTROINTESTINAL AND MOTOR ACTIVITY OF THE STOMACH BY APPLYING PLACENTA CRYOEXTRACT","authors":"F. Hladkykh, M. Chyzh","doi":"10.25040/ntsh2021.01.08","DOIUrl":"https://doi.org/10.25040/ntsh2021.01.08","url":null,"abstract":"Introduction. Current approaches to reducing the ulcerogenicity of nonsteroidal anti-inflammatory drugs are aimed primarily at eliminating the damaging effect on the gastric mucosa, and according to the literature, the use of proton pump inhibitors can even worsen the course of enteropathy. Objectives. To characterize the influence of cryopreserved placenta extract on the state of secretory and motor-evacuation activity of the stomach under the conditions of experimental meloxicam-induced gastropathy and enteropathy. Methods. Serial randomized placebo-controlled studies were performed on nonlinear rats and mice using a model of small intestine-induced gastrointestinal lesions. Gastric secretion in rats, gastric evacuation function and intestinal motor function in mice were studied with the help of standard methods. Results. The administration of meloxicam leads to a statistically significant increase (p <0.05) in the volume of gastric secretion by 31.6±7.3%, an increase in total acidity (p=0.002) by 7.7 [7.7; 16.6]% and a statistically significant increase (p<0.05) in peristaltic activity by 18.9% relative to intact animals. The administration of cryopreserved placenta extract led to a statistically significant (p=0.002) decrease in the ratio of free and total acidity by 2.3 times, with a statistically significant decrease (p<0.05) by 14.5% in peristaltic activity relative to intact animals. The combined threaded administration of meloxicam and cryopreserved placenta extract was accompanied by a decrease in the ratio of free and total acidity by 43.0±3.0%. Conclusion. The combined application of placental cryoextract and meloxicam eliminates meloxicam-induced hypersecretion of gastric juice and gastric hypermobility. The cryoextract has also proved to reduce the aggressiveness of gastric juice by reducing its free and increasing combined acidity.","PeriodicalId":140699,"journal":{"name":"Proceedings of the Shevchenko Scientific Society. Medical Sciences","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126333332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"RESEARCH INVOLVING HUMAN SUBJECTS IN UKRAINE: HOW TO LEVERAGE ARISING OPPORTUNITIES?","authors":"A. Cherkas","doi":"10.25040/ntsh2021.01.02","DOIUrl":"https://doi.org/10.25040/ntsh2021.01.02","url":null,"abstract":"The review of the applications for grants of the National Research Foundation of Ukraine revealed evidence that many applicants-clinicians are not aware of the principles of Good Clinical Practice (GCP) that are implemented in different forms in the vast majority of research involving human subjects across the globe. In the essay, based on the experience of researching at Danylo Halytsky Lviv National Medical University (Ukraine), Loma Linda University (USA), Friedrich Schiller University Jena (Germany), as well as industry (Sanofi-Aventis-Deutschland GmbH., Frankfurt am Main, Germany), the author shares his thoughts about the gaps in education, training, regulations and administrative flaws that prevent more rapid progress in clinical research in Ukraine. Despite the complexity of the problem, implementation of relatively simple steps at institutional and/or national levels, as suggested, can boost the efficiency of research, increase the quality of applications and move clinical research in Ukraine to a qualitatively different level","PeriodicalId":140699,"journal":{"name":"Proceedings of the Shevchenko Scientific Society. Medical Sciences","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131040953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"VACCINATION AND EXTREMELY DANGEROUS INFECTIONS: ACHIEVEMENTS AND PROSPECTS","authors":"N. Vynograd, Zoriana Vasylyshyn, Lyudmyla Kozak, U. Shul, Iryna Baydalka","doi":"10.25040/ntsh2021.01.04","DOIUrl":"https://doi.org/10.25040/ntsh2021.01.04","url":null,"abstract":"Introduction. Infectious diseases have been a threat during all periods of human existence. Primary measures to protect against extremely dangerous pathogens included quarantine, observation and vaccination. Vaccination was crucial in the fight against smallpox - the only disease, which was eradicated on a global scale. The aim of the work was to identify the main stages of development and application of vaccines for the protection against extremely dangerous infections (EDI) and the contribution of Ukrainian scientists in the development of vaccines for EDI. Methods. An analysis using the Search Strategy of narrative reviews of literary sources and Internet resource was conducted to systematize data about the application of immunobiological preparations to create an active immunity against several actual EDI. The participation of scientists with Ukrainian roots in the creation of vaccines against this group of diseases is indicated. Results. Smallpox (variolation in China in the 11th century) is known as the first disease against which specific protection was created. Until the 20s century, the first five vaccines against EDI were developed: smallpox, rabies, anthrax, cholera, and plague. In the 20s century, the list was supplemented by vaccines against typhus, yellow fever, tick-borne encephalitis, tularemia, brucellosis, coxiellosis (Q-fever), hemorrhagic fever with renal syndrome (HFRS). The introduction of new technologies in the 21st century allowed improving existing preparations and creating new ones against Ebola viral disease (EVD), COVID-19 as EDIs relevant ones for the pandemic potential. Outstanding scientists with Ukrainian roots contributed to the creation of vaccines against EDI: V. Khavkin, D. Samoilovich, V. Zhdanov. Conclusion. Protection of the population against EDIs is limited by the number of available effective vaccines. The development of vaccines against COVID-19 has improved the prognosis for containment of the COVID-19 pandemic.","PeriodicalId":140699,"journal":{"name":"Proceedings of the Shevchenko Scientific Society. Medical Sciences","volume":"89 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114888247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"SPIKE PROTEIN AND ITS PROTEASES ROLE IN SARS-COV-2 PATHOGENICITY AND TREATMENT; A REVIEW","authors":"Fateme Tavakoli Far, Ehsan Amiri-Ardekani","doi":"10.25040/ntsh2021.01.05","DOIUrl":"https://doi.org/10.25040/ntsh2021.01.05","url":null,"abstract":"Since December 2019, a novel beta coronavirus has spread around the world. This virus can cause severe acute respiratory syndrome (SARS). In this study, we reviewed proteases of SARS-CoV-2 based on related articles published in journals indexed by Scopus, PubMed, and Google Scholar from December 2019 to April 2020. Based on this study, we can claim that this coronavirus has about 76% genotype similarity to SARS coronavirus (SARS-CoV). Also, similarities between these two viruses have been found in the mechanism of entry into host cells and pathogenicity. ACE 2, the angiotensin convertase enzyme 2, plays a role in the Renin-Angiotensin-Aldosterone system (RAAS) and blood pressure regulation. Some mechanisms have been reported for the role of ACE 2 in the pathogenicity of SARS-CoV-2. For example, the interaction between the ACE 2 receptor and spike protein mediated by TMPRSS2, Cathepsin B/L, and other enzymes is responsible for the entry of the virus into human cells and pathogenicity. Some host cell endosomal enzymes are necessary to cleavage coronavirus spike protein and cause binding to their common receptor. So, we conclude that molecules like antibodies or small molecules like ACE 2 antagonists and soluble ACE 2 can be used as a good therapeutic candidate to prevent SARS-CoV-2.","PeriodicalId":140699,"journal":{"name":"Proceedings of the Shevchenko Scientific Society. Medical Sciences","volume":"87 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124165117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"IVAN PULUJ AND THE DISCOVERY OF X-RAYS","authors":"U. Pidvalna, R. Plyatsko, V. Lonchyna","doi":"10.25040/ntsh2021.01.18","DOIUrl":"https://doi.org/10.25040/ntsh2021.01.18","url":null,"abstract":"On January 5, 1896, the Austrian newspaper Die Presse published an article entitled “A Sensational Discovery”. It was dedicated to the discovery of X-rays made on November 8, 1895 by the German physicist Wilhelm Conrad Röntgen. Having taken into account the contribution of other scientists, the precondition of the given epochal, yet unexpected, discovery was, first and foremost, the work of the Ukrainian scientist Ivan Puluj. It was Puluj who laid the foundation for X-ray science. He explained the nature of X-rays, discovered that they can ionize atoms and molecules, and defined the place of X-ray emergence and their distribution in space. In 1881, Puluj constructed a cathode lamp (“Puluj’s tube”) which was fundamentally a new type of light source. In the same year, in recognition of this discovery, Puluj received an award at the International Exhibition in Paris. Investigating the processes in cathode-ray tubes, Ivan Puluj set the stage for two ground-breaking discoveries in physics, namely X-rays and electrons. Puluj used his cathode lamp in medicine as a source of intense X-rays which proved to be highly efficient. The exact date of the first X-ray images received by Puluj remains unknown. High-quality photographs of the hand of an eleven-year-old girl, taken on January 18, 1896, are preserved. Multiple X-ray images clearly visualized pathological changes in the examined structures (fractures, calluses, tuberculous bone lesions). High-quality images were obtained by means of the anticathode in the design of Puluj’s lamp, which was the first in the world. The image of the whole skeleton of a stillborn child (published on April 3, 1896 in The Photogram) is considered to be the starting point of using X-rays in anatomy.","PeriodicalId":140699,"journal":{"name":"Proceedings of the Shevchenko Scientific Society. Medical Sciences","volume":"529 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131950505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"THE SYNERGY OF THE WORLD AND UKRAINIAN EXPERIENCES","authors":"Oksana Zayachkivska, V. Lonchyna","doi":"10.25040/ntsh2020.02.01","DOIUrl":"https://doi.org/10.25040/ntsh2020.02.01","url":null,"abstract":"The COVID-19 pandemic and the resultant economic downturn has brought to the forefront the need for expeditious action to create answers for the diagnosis, treatment and prevention of this newest human malady. This crisis has crystalized the prioritization of expenditures of resources for medical research, clinical practice and public health measures in combating this deadly virus. The Johns Hopkins School of Public Health Coronavirus Resource Center has counted a total of 46,168,459 cases and 1,196,891 deaths worldwide (November 1, 2020). The data for Ukraine is 407,573 cases and 7,515 deaths. It is now 10 months since the recognition of the worldwide involvement of the SARS-COV-2 virus as the etiologic agent of this pandemic. Although progress has been made, there is still a large gap in our efforts to find a cure and create an effective vaccine for the world population. A corollary lesson is the need for life-long learning and the acceptance of change in everyday practice. Harvard and Ukrainian Catholic University Professor of business management Adrian Slywotzky develops a succinct idea in his book «David Conquers: The Discipline of Asymmetric Victory». He states that David’s sling is a modest investment that results in a giant return. Such is our modest investment in this scholarly medical journal: Proceedings of the Shevchenko Scientific Society. Medical Sciences. We rely heavily on the social media mechanism of «word-of mouth» to promote our journal and its offerings of current medical breakthroughs and findings. Our wide range of interest is underscored by the more than 101 countries from whence our readers query our online journal. This is our modest investment on behalf of our readers to gain current information, an example of our asymmetric battle with the giant coronavirus. In this issue (Vol. 59, No.2 [62]) we inaugurate a video supplement of the proceedings of the Fourth International Symposium “SMARTLION2020’ which took place as a virtual meeting on 29 September 2020. O Danyliak and I Stryjska have collated the sessions related to the coronavirus pandemic. [4] The speakers include: 1. Boris Lushniak, Professor and Dean, School of Public Health, University of Maryland, USA: «A short history of pandemics». 2. Serhuy Souchelnytskyi, Professor at the College of Medicine, Quatar University, Doha, Quatar: «Why is COVID-19 so aggressive? Molecular insights with clinical application». 3. Andriy Cherkas, PhD candidate, Scientist, Sanofi, Frankfurt am Main, Germany: «COVID-19 and diabetes - a dangerous combination». 4. Armen Gasparyan, Associate Professor of Medicine, University of Birmingham, UK and Expert Reviewer of SCOPUS journals: «Infodemic and Misinformation in the COVID-19 era». 5. Oksana Souter, PhD, CEO of Swiss Organic Solutions, Zurich, Switzerland: “The systemic evaluations of proximity tracing app SwissCovid.” Next, S Souchelnytsky discusses the effectiveness of coronavirus testing that relies on the identification of the infra","PeriodicalId":140699,"journal":{"name":"Proceedings of the Shevchenko Scientific Society. Medical Sciences","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126988132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"CHANGING RESEARCH PARADIGM IN THE FACE OF A GLOBAL PANDEMIC: FORESEEABLE IMPACT AND ADAPTIVE MEASURES IN ACADEMIC RESEARCH IN THE FUTURE","authors":"Latika Gupta, Prithvi Sanjeevkumar Gaur","doi":"10.25040/ntsh2020.02.05","DOIUrl":"https://doi.org/10.25040/ntsh2020.02.05","url":null,"abstract":"The Coronavirus disease 2 (Covid-19) pandemic has led to a massive rise in research in a bid to understand more about the new disease and cope better with the pandemic. The need to socially distance and limited human movement in open spaces since the COVID-19 outbreak have brought most forms of research to a standstill. While most research incentives have been directed towards research regarding the pandemic, diminished patient visits, have paralysed all the studies requiring personal and physical examination. Majority of the social interactions have been reduced to a screen, and this is also the new practice in the research realm. This unique situation calls for a need to re-examine research practices and reinvent novel methods for quality research. While it is prudent to step up research to understand the disease and its impact on varied conditions, the situation also necessitates a close watch for misinformation, erroneous reporting, and failure of ethical research. Moreover, there is a felt need to derive validated tools for remote assessment to minimise risk to the patients and physicians alike. In this brief, we discuss the perceived changes and potential areas for erroneous research reporting while providing possible solutions for fruitful research in the peri-pandemic period. We also identify new methods of conducting studies and the setbacks that could be faced while carrying out such tasks, including those of methodological, ethical and financial nature. We hope these may shape researcher perspectives and help them to conduct ethical and valid research in these, particularly trying times.","PeriodicalId":140699,"journal":{"name":"Proceedings of the Shevchenko Scientific Society. Medical Sciences","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123826988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"APPRECIATION TO THE EDITORIAL BOARDS, PRODUCTION TEAMS, REVIEWERS AND AUTHORS FOR THE PROCEEDING OF THE SHEVCHENKO SCIENTIFIC SOCIETY. MEDICAL SCIENCES IN 2020","authors":"Oksana Zayachkivska, M. Kovalska","doi":"10.25040/ntsh2020.02.15","DOIUrl":"https://doi.org/10.25040/ntsh2020.02.15","url":null,"abstract":"We would like to thank our past and present editorial and production teams and our authors for cooperation in 2020. Despite of COVID-19 challenges in 2020, our journal has recently received acceptations to the Directory of Open Access Journals (DOAJ) and in processing to Ulrichsweb & Ulrichs Periodicals Directory. The Proceedings of Shevchenko Scientific Society. Medical Sciences obtains manuscripts over the world [1-8]. The decision on their publications is based on potentially influential contents of interest to Ukrainian and other medical and healthcare professionals, scientists and medical students after successful critical peer review [9]. All of the editorial staff of The Proceedings of Shevchenko Scientific Society. Medical Sciences sincerely appreciates the authors’ contributions. Among them, the best corresponding authors (based on download counts of their articles and positive social media attention) are Dr. Sandor Szabo (American University Health Science, CA, USA) and Dr. Natalia Matolinets (Danylo Halytsky Lviv National Medical University, Lviv, Ukraine). In 2020, The Proceedings of Shevchenko Scientific Society. Medical Sciences has put all efforts to upgrade the Journal peer review standards, offering regular educational courses/webinars to advance their editorial credentials to better serve the professional interests of the Journal readers. The Proceedings of Shevchenko Scientific Society. Medical Sciences invited new editorial board members and experts for peer review of the manuscripts in 2020, and some of them received multiple invitations. We honestly appreciate the voluntary contribution of all of the members of the editorial team, executive, and editorial boards of PSSS MS and all reviewers as introduced below. Among reviewers, top peer reviewers (based on their contribution of 4 or more reviews) are Dr. Andriy Cherkas (Sanofi-Aventis-Deutschland GmbH – Industriepark Höchst, Frankfurt am Main, Germany), Dr. Nelia Oryshchyn (Danylo Halytsky Lviv National Medical University, Lviv, Ukraine), Dr. Vassyl Lonchyna (University of Chicago Pritzker School of Medicine, Chicago, United States).","PeriodicalId":140699,"journal":{"name":"Proceedings of the Shevchenko Scientific Society. Medical Sciences","volume":"2014 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125638908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}